Extensive Sinonasal and Oropharyngeal Necrosis as a Consequence of Adulterated Cocaine with Mimicry of ANCA-Positive Vasculitis

Extensive Sinonasal and Oropharyngeal Necrosis as a Consequence of Adulterated Cocaine with Mimicry of ANCA-Positive Vasculitis

Bibliographic Details
Main Authors:	Adnan S. Hussaini MD, Cara K. Black, Sonya Malekzadeh MD, Gregory J. Milmoe MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-12-01
Series:	OTO Open
Online Access:	https://doi.org/10.1177/2473974X19894239

Similar Items

Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis
by: Qiuyu Jin, et al.
Published: (2018-11-01)

p-ANCA-Associated Vasculitis Caused by Levamisole-Adulterated Cocaine: A Case Report
by: Michelle R. Carter, et al.
Published: (2013-01-01)

Levamisole-adulterated Cocaine Induced Vasculitis with Skin Ulcerations
by: Malford T. Pillow, et al.
Published: (2013-03-01)

ANCA-Associated Intrahepatic Duct Injury Associated with Levamisole-Adulterated Cocaine
by: Joshua K. Salabei, et al.
Published: (2020-01-01)

Levamisole-Adulterated Cocaine Induced Skin Necrosis of Nose, Ears, and Extremities: Case Report
by: Lauren A. Lawrence M.D., et al.
Published: (2014-09-01)

Vanishing vasculitis: a case of acute necrotic skin findings without pathologic features of vasculitis from adulterated cocaine
by: Adnan Asif Parvez Ghias, et al.
Published: (2017-10-01)

Differentiation of Cocaine-Induced Midline Destructive Lesions from ANCA-Associated Vasculitis
by: Alireza Mirzaei, et al.
Published: (2018-09-01)

Levamisole-Contaminated Cocaine: An Emergent Cause of Vasculitis and Skin Necrosis
by: Osama Souied, et al.
Published: (2014-01-01)

Adulterants in crack cocaine in Brazil
by: Marcelo Ribeiro, et al.

Immunopathogenesis of ANCA-Associated Vasculitis
by: Andreas Kronbichler, et al.
Published: (2020-10-01)

Epidemiology of ANCA associated vasculitis
by: Wenche Koldingsnes, et al.
Published: (2008-01-01)

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

ANCA-positive vasculitis: Clinical implications of ANCA types and titers
by: Vital Manuel Da Silva Domingues, et al.

Sinonasal Involvement in Systemic Vasculitides and Cocaine-Induced Midline Destructive Lesions: Diagnostic Controversies
by: M. Armengot M.D., Ph.D., et al.
Published: (2013-09-01)

Recalcitrant and severe pyoderma gangrenosum attributable to levamisole-adulterated cocaine and treated successfully with oral tofacitinib
by: Andrew W. Choi, MD, et al.
Published: (2020-09-01)

Phenytoin Toxicity from Cocaine Adulteration
by: Carlos J. Roldan
Published: (2014-03-01)

Animal Models of ANCA Associated Vasculitis
by: Lani Shochet, et al.
Published: (2020-04-01)

Individualization of the ANCA associated vasculitis treatment
by: Zbigniew Zdrojewski
Published: (2014-09-01)

Treatment of Renal ANCA-associated Vasculitis
by: Mafalda Teixeira da Costa
Published: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
by: Antje Müller, et al.
Published: (2021-06-01)

Renal limited ANCA-positive vasculitis: a rare manifestation of a rare disease
by: Ali Jawad Jang Khan MD, et al.
Published: (2020-11-01)

Cocaine‐related vasculitis
by: Hassan Liaqat, et al.
Published: (2020-12-01)

Cocaine-Induced Vasculitis
by: Mark Berman, et al.
Published: (2016-10-01)

Pyoderma gangrenosum–like facial ulcers in a woman associated with cocaine use and cANCA/anti-PR3+, pANCA/anti-MPO– serology
by: Jeffrey D. McBride, MD, PhD, et al.
Published: (2020-09-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-01-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-09-01)

ANCA-associated vasculitis in childhood: recent advances
by: Marta Calatroni, et al.
Published: (2017-05-01)

Why are patients with ANCA-associated vasculitis fatigued?
by: McClean, Andrew
Published: (2016)

Biological therapy in the treatment of ANCA associated vasculitis
by: Smith, Rona Marie
Published: (2016)

Autoreactive B Cells in ANCA-Associated Vasculitis
by: Berti, Alvise
Published: (2021)

ANCA-Associated Vasculitis Co-Occurrence With Systemic Sclerosis: A Case Report of a Rare Diagnostic Dilemma
by: Jordana Cheta MD, et al.
Published: (2018-06-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
by: Sayo Takeda, et al.
Published: (2019-06-01)

Long- term outcome of paediatric patients with ANCA vasculitis
by: Pusey Charles D, et al.
Published: (2011-06-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
by: Naohiro Yoshida, et al.
Published: (2014-01-01)

Is rituximab effective for induction of remission in ANCA-associated vasculitis?
by: Carmen Rain, et al.
Published: (2015-08-01)

Endothelial dysfunction of vessels at ANCA-associated systemic vasculitis
by: L. V. Sedaia, et al.
Published: (2015-08-01)

Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis
by: Rafeel Syed, et al.
Published: (2015-01-01)

GENETIC SUSCEPTIBILITY TO ANCA-ASSOCIATED VASCULITIS: STATE OF THE ART
by: Francesco eBonatti, et al.
Published: (2014-11-01)